Transchromosomic Hens Producing Biotherapeutic Drugs

Award Information
Agency: Department of Agriculture
Branch: N/A
Contract: 2006-33610-16842
Agency Tracking Number: 2006-00142
Amount: $80,000.00
Phase: Phase I
Program: SBIR
Awards Year: 2006
Solicitation Year: N/A
Solicitation Topic Code: N/A
Solicitation Number: N/A
Small Business Information
AviGenics, Inc.
111 Riverbend Rd., Athens, GA, 30605
DUNS: N/A
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 Dawn Eberhardt
 (706) 227-1170
 eberhardt@avigenics.com
Business Contact
 Jim Early
Title: Senior Vice President
Phone: (206) 227-1170
Email: jearly@avigenics.com
Research Institution
N/A
Abstract
Basic science discoveries have led to the development of a series of human biotherapeutic drugs for the treatment of cancer and HIV as well as many other diseases. Currently there are over 400 drugs in clinical trials just for the first two diseases. The current biotherapeutics' manufacturing platforms have not kept pace resulting in a dramatic rise in treatment cost and more importantly unmet therapeutic needs. Avian transgenesis is an emerging technology that has the potential to radically increase the US manufacturing capacity of biotherapeuticals. AviGenics, Inc proposes a novel recombinant protein manufacturing platform that will allow us to express human therapeutic molecules in the egg white of hens.

* information listed above is at the time of submission.

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government